Protagenic Therapeutics, Inc. (PTIX )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol PTIX
- Company Protagenic Therapeutics, Inc.
- Price $0.56
- Changes Percentage -5.1
- Change -0.0301
- Day Low $0.55
- Day High $0.56
- Year High $14.28
- Year Low $0.25
- Market Cap $944,670
- Price Avg 50 EMA (D) $0.56
- Price Avg 200 EMA (D) $2.41
- Exchange NASDAQ
- Volume 10,533
- Average Volume 66,993
- Open $0.55
- Previous Close $0.59
- EPS -13.13
- PE -0.04
- Earnings Announcement 2026-05-11 10:59:00
- Shares Outstanding $1,927,898
Company brief: PROTAGENIC THERAPEUTICS, INC. (PTIX )
- Healthcare
- Biotechnology
- Dr. Garo H. Armen Ph.D.
- https://www.protagenic.com
- US
- N/A
- 04-27-2021
- US74365N2027
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.